Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN5A | Q14524 | 1/20 | 0.35 |
| ▸ | KCNH2 | Q12809 | 8/20 | 0.34 |
| ▸ | GFER | P55789 | 1/20 | 0.33 |
| ▸ | EEF2K | O00418 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14432200 | 1.00 | SCN5A (0.35) | SCN5AKCNH2GFEREEF2K | |
| SCHEMBL4519617 | 0.93 | KCNH2 (0.34) | SCN5AKCNH2GFEREEF2K | |
| SCHEMBL4519605 | 0.93 | KCNH2 (0.34) | SCN5AKCNH2GFEREEF2K | |
| SCHEMBL4519609 | 0.93 | KCNH2 (0.34) | SCN5AKCNH2GFEREEF2K | |
| SCHEMBL4501914 | 0.91 | KCNH2 (0.37) | KCNH2 | |
| SCHEMBL4515235 | 0.91 | KCNH2 (0.37) | KCNH2 | |
| SCHEMBL4501910 | 0.91 | KCNH2 (0.37) | KCNH2 | |
| SCHEMBL4515232 | 0.91 | KCNH2 (0.37) | KCNH2 | |
| SCHEMBL4501922 | 0.91 | KCNH2 (0.37) | KCNH2 | |
| SCHEMBL4513118 | 0.85 | EEF2K (0.39) | SCN5AKCNH2EEF2K |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070191333-A1 | Antibacterial agents | WARNER LAMBERT COMPANY LLC | 2007-08-16 | — | — | US | disclosed |
| EP-1687296-A1 | ANTIBACTERIAL AMINOQUINAZOLIDINEDIONE DERIVATIVES | Warner-Lambert Company LLC (US) | 2006-08-09 | — | — | EP | disclosed |
| WO-2005049605-A1 | ANTIBACTERIAL AMINOQUINAZOLIDINEDIONE DERIVATIVES | WARNER-LAMBERT COMPANY LLC (US) | 2005-06-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070191333-A1 | Antibacterial agents | MRPL21, RPN2, FBL | SCN5A 3616/4885KCNH2 2633/4885GFER 1342/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.